Skip to search formSkip to main contentSkip to account menu

antineoplastons

Known as: Antineoplaston Agent, antineoplaston 
A peptide, amino acid derivative, and/or organic acid extracted from blood serum, urine, or synthesized chemically, that inhibits the methylation of… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
We have investigated protein kinase C (PKC) signaling, a putative differentiation-related and metastasis suppressor gene Cap43… 
2006
2006
Strategies for the treatment of childhood cancer have changed considerably during the last 50 years and have led to dramatic… 
2005
2005
Antineoplastons such as A10 include naturally occurring peptides and amino acid derivatives that control the neoplastic growth of… 
2004
2004
From December 1991 to December 1995, the National Cancer Institute (NCI) initiated phase II clinical trials of A10 and AS2-1… 
1995
1995
Antineoplastons, which were firstly described by Burzynski, are naturally occurring peptides and amino acid derivatives which… 
1990
1990
Successful treatment of advanced cancer of the prostate which no longer responds to hormonal manipulation continues to be a… 
1990
1990
The essential biological importance of antineoplastons has motivated the present theoretical and experimental studies on the… 
1987
1987
Antineoplaston A5 is a mixture of small peptides and amino acid derivatives isolated from human urine which show a unique pattern… 
1987
1987
Antineoplaston A10 (3-phenylacetylamino-2,6-piperidinedione), a peptide analogue originally isolated from human urine, has been… 
1977
1977
Twenty-one patients with advanced cancer or leukemia were treated with antineoplaston A and followed for up to nine months…